Scientific Advisors

Alessandra Biffi and Paolo Fiorina are world-renowned scientists and key-opinion-leaders with deep expertise and experience in autoimmune diseases and gene&cell therapy.

Alessandra Biffi is the current Director of the Gene Therapy Program, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, of the Program for Gene Therapy in Rare Diseases in the Department of Medicine of Boston Children’s Hospital, is the Faculty Director for Gene Therapy at Dana-Farber Cancer Institute, Principal Scientist at the Harvard Stem Cell Institute, Chair of the Scientific Review Committee for Gene Therapy at Boston Children’s Hospital, and Associate Professor of Pediatrics Harvard Medical School.

Paolo Fiorina is Director, International Center for T1D, Romeo ed Enrica Invernizzi Pediatric, University of Milan, Italy; Professor of Endocrinology, L. Sacco Hospital, University of Milan; Chief of Division of Endocrinology, ASST Sacco-Fatebenefratelli, Milan, Italy and Lecturer on Pediatrics, Boston Children’s Hospital, Harvard Medical School. He is actively involved in the Grant Committee of JDRF, Medical Science Review Committee (MSRC) for Islet Biology and Transplantation, Transplant Meeting Committee at the San Raffaele Hospital (Milan), American Heart Association (AHA), and American Society of Transplantation (AST).